Backed by extensive experience in technology and healthcare sectors, the fund manager has successfully navigated over 30 deals across North America and Europe. Their strategic approach is characterized by a data-driven investment style, emphasizing operator-first methodologies that prioritize strong management teams. With several notable exits, including a successful exit in the biotech space, they focus on early to growth-stage investments. This combination of regional expertise and thematic investment strategies positions the manager for continued success in dynamic markets.